|
Employed
|
Terminated
|
Details about your lobbyist or lobbyist entity's efforts
|
|
01/01/2014
|
|
Various matters relating to the implementation of Chapter 224 the Acts of 2012, Pharmaceutical Cost Containment Commission, drug innovation, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing related policies, Massachusetts Life Sciences Center, research and development, taxation policies, drug safety, greenbio policies and FY 2015 budget. H.27, H.39, H.49, H.184, H.192, H.304, H.678, H.701, H.825, H.978, H.999, H.1052, H.1082, H.1927, H.1933, H.1940, H.1949, H.1953, H.1962, H.1977, H.1978, H.1988, H.1992, H.2012, H.2018, H.2020, H.2033, H.2061, H.2065, H.2082, H.2096, H.2108, H.2112, H.2415, H.2536, H.2621, H.2646, H.2774, H.3327, H.3330, H.3379, H.3381, H.3382, H.3399, H.3415, H.3535, H.3544, H.3547, H.3548, H.3558, H.3559, H.3560, H.3561, H.3562, H.3563, H.3564, H3565, H.3566, H.3585, H.3600, H.3611, H.3667, H.3672, H.3677, H.3695, H.3700, H.3707, H.3708, H.3711, H.3734, H.3757, H.3763, H.3770, S.103, S.127, S.193, S.300, S. 399, S.400, S.439, S.477, S.483, S.534, S.543, S.569, S.767, S.907, S.917, S.986, S.995, S.1015, S.1029, S.1040, S.1050, S.1051, S.1052, S.1053, S.1069, S.1090, S.1220, S.1334, S.1344, S.1360, S.1378, S.1528, S.1766, S.1770, S.1776, S.1778, S.1812, S.1817, S. 1890, S.1891, S.1899, S.1907, S.1922, S.1926, H.808, H.813, H.1936, H.1946, H.1947, H.2037, H.2093, H.2935, H.2968, S.354, S.387, S.390, S.1059, S.1498, S.1564, S.1565, S.1575, S.1583, S.1586, S.1603
|
|